AKI Risk Assessment, Challenges and Opportunities
Rapidly assess the risk of acute kidney injury (AKI), a common — and often fatal — condition with few early warning signs
Oct 1, 2016
Duration: 22 minutes
Dr. Lakshmi Ramanathan delivers a comprehensive review of AKI, which can lead to poor patient outcomes when not detected at an early stage. She also shares encouraging results from a study assessing AKI risk in ICU patients using the NephroCheck® Test.
This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.
About Our Speaker:
About Our Speaker:
Lakshmi V. Ramanathan, PhD
Service Chief, Clinical Chemistry
Memorial Sloan Kettering Cancer Center
Dr. Ramanathan's clinical responsibilities include oversight of one of the busiest Chemistry Hospital Laboratories in New York City, performing approximately 5 million tests annually. She is the 2016 President of the New York Metro section of the American Association of Clinical Chemistry (AACC) and the Founding Chair for the Division on Tumor Markers and Cancer Diagnostics of AACC.
Dr. Ramanathan's clinical responsibilities include oversight of one of the busiest Chemistry Hospital Laboratories in New York City, performing approximately 5 million tests annually. She is the 2016 President of the New York Metro section of the American Association of Clinical Chemistry (AACC) and the Founding Chair for the Division on Tumor Markers and Cancer Diagnostics of AACC.
